1-2 of 2
Matteo G. Carrabba
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract LB563: Integrated multiomic profiling identifies the epigenetic regulator PRC2 as a therapeutic target to counteract leukemia immune escape and relapse

Valentina Gambacorta, Stefano Beretta, Martina Ciccimarra, Laura Zito, Kety Giannetti, Angela Andrisani, Daniela Gnani, Lucia Zanotti, Giacomo Oliveira, Matteo G. Carrabba, Davide Cittaro, Ivan Merelli, Fabio Ciceri, Raffaella Di Micco, Luca Vago
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): LB563.
https://doi.org/10.1158/1538-7445.AM2022-LB563
Published: 15 June 2022
View articletitled, Abstract LB563: Integrated multiomic profiling identifies the epigenetic regulator PRC2 as a therapeutic target to counteract leukemia immune escape and relapse
Journal Articles

Suboptimal Activation of CD8+ T Cells by Melanoma-derived Altered Peptide Ligands: Role of Melan-A/MART-1 Optimized Analogues

Matteo G. Carrabba, Chiara Castelli, Markus J. Maeurer, Paola Squarcina, Agata Cova, Lorenzo Pilla, Nicolina Renkvist, Giorgio Parmiani, Licia Rivoltini
Journal: Cancer Research
Cancer Res (2003) 63 (7): 1560–1567.
Published: 01 April 2003
View articletitled, Suboptimal Activation of CD8+ T Cells by Melanoma-derived Altered Peptide Ligands: Role of Melan-A/MART-1 Optimized Analogues
Open the PDF for Suboptimal Activation of CD8+ T Cells by Melanoma-derived Altered Peptide Ligands: Role of Melan-A/MART-1 Optimized Analogues in another window